Prognostic and clinicopathological value of myeloid-derived suppressor cells in lung cancer: a comprehensive systematic review and meta-analysis
OncologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Expert review of anticancer therapy
- Publicado em
- 18 nov 2025
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Prognostic and clinicopathological value of myeloid-derived suppressor cells in lung cancer: a comprehensive systematic review and meta-analysis
Fateme Sheida, Nadia Alipour, Aida Naseri, Sepideh Razi, Gita Manzari Tavakoli, Seyed Javad Moghaddam, Nastaran Karimi, Nima Rezaei
Descritores MeSH
- Myeloid-Derived Suppressor Cells
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Small Cell Lung Carcinoma
- Disease Progression
- Prognosis
- Biomarkers, Tumor
- Progression-Free Survival
- Survival Rate
- Humans
Veja também
Estudos relacionados
- Prognostic role of Naples prognostic score in lung cancer: a meta-analysis
- PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Chinese patients with advanced non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized controlled trials
- Predictive role of circulating tumor DNA based molecular residual disease for long-term outcomes in non-small cell lung cancer patients: a meta-analysis
- Prognostic and clinicopathological value of fibrinogen-to-albumin ratio in non-small cell lung cancer: a meta-analysis